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ABSTRACT 
Gay and bisexual men infected with human immunodeficiency virus (HIV) comprise a sizeable, 
medically vulnerable population. Depression is the most commonly experienced mental health 
disorder affecting this group of people, lending itself to a host of risks associated with 
depression. As screening of depression in this population can be challenging, it is vital that 
clinicians have the best available tools and guidelines to detect depressive symptomology. This 
focused, comprehensive review of the literature examined current data describing the clinical 
instruments used to detect depressive symptoms in HIV-infected gay and bisexual men. The aim 
of this analysis was to seek out which instruments were the most widely and successfully 
employed for this population. An initial search using EBSCOhost and associated databases 
CINAHL, MEDLINE, PsycINFO, and Health and Psychosocial Instruments alongside inclusion 
and exclusion criteria found 1,899 articles. Results were narrowed using additional inclusion and 
exclusion criteria and relevancy, yielding a total of 13 articles for review. The findings of this 
review suggest screening of depressive symptoms in HIV-infected gay and bisexual men was 
most successful using the CES-D, the BSI-18, and the BDI. Health care providers should have an 
understanding of the importance in assessing this population for depression and have access to 
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Background and Significance 
Human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system 
causing severe immunocompromisation and susceptibility to various sequelae (Mulryan, 2010).  
The function of a retrovirus is to infect a host cell through injection of ribonucleic acid (RNA); 
which, through a series of cellular processes, becomes deoxyribonucleic acid (DNA) (Mulryan, 
2010). This process is what allows HIV to commandeer healthy cells and use them to create 
“daughter” cells for further distribution throughout the host.  HIV is transmitted during exposure 
to infected body fluids allowing the virus to move from person to person. The infected body 
fluids with the highest concentrations of HIV are blood, semen, vaginal secretions, colostrum, 
and cerebrospinal fluid (Mulryan, 2010). Transmission is defined by the infectious body fluid of 
origin and is comprised of three main routes: sexual practices, contact with infected blood, and 
vertical transmission from mother to fetus or mother to a breastfeeding child (Mulryan, 2010).  
According to the Centers for Disease Control and Prevention (CDC), minority groups are 
at highest risk for developing HIV infection. These include: gay men (men with same-sex sexual 
behavior), bisexual men (men with same-sex and opposite-sex sexual behavior), IV drug users, 
sex workers, prison populations, and economically disadvantaged individuals.  This can be 
explained by lack of access to testing, lack of regular medical care, lack of preventative measures 
such as condoms or pre-exposure prophylaxis (PrEP), substance abuse, unstable housing, lack of 
employment, and mental health disorders such as depression (Blank et. al, 2014). 
Literature indicates that depression is reported as the most common mental health 
diagnosis for people living with HIV/AIDS (PLWHA); it is as much as 1.99 times more 
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prevalent than in HIV-negative persons (Sherr et. al, 2011).  Furthermore, 22 to 54 percent of 
PLWHA in the United States reportedly experience depression and depressive symptoms. There 
is significant evidence to suggest that infection with HIV may influence the development of 
depression through a multifactorial process, including factors such as societal stigma, felt stigma 
(the awareness of discrimination from external sources), necessary adherence to a lifelong 
medication regimen, lack of familial or social support and changes in body image related to 
disease progression (Sherr, Clucas, Harding, Sibley, & Catalan, 2011).  Additionally, there is 
evidence to suggest that depression acts as a precursor to the development of HIV through 
suppressing immune functioning prior to infection and potentiating risk factors of transmission 
behaviors. Some of these behaviors include not adhering to prescribed drug regimen, engaging in 
unprotected sexual intercourse, engaging with higher numbers of sexual partners, and abusing 
substances.  
The vast majority of PLWHA are minorities; as such, they experience a significant 
amount of stigmatization.  This stigmatization of PLWHA, particularly against gay and bisexual 
men, is defined as devaluation due to discrimination, labeling, attributing damaging qualities, 
and separation from society (Ramirez-Valles, Molina, & Dirkes, 2013). According to Ramirez-
Valles and colleagues (2013), attribution theory is a framework that describes how negative 
labels are incurred on PLWHA and how these labels stem from the belief that HIV-infected 
people are deserving of their diagnosis. Individuals attribute the cause of a characteristic to an 
inference about the characteristics’ responsibility. Once an inference is developed an emotional 
reaction occurs later evolving into a behavioral response, such as separation (Ramirez-Valles et. 
al, 2013). An example of attribution theory in this study might be: an outside individual views a 
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gay man infected with HIV as being responsible for his diagnosis and subsequently separates 
from him. As a result of blame and stigmatization, HIV positive individuals experience societal 
isolation, guilt about their status, anxiety, and suicidality (Sivasubramanian et. al, 2011). 
Additionally, this contributes greatly to the development and severity of depression and 
depressive symptomology.  
Depression is a highly debilitating illness; and its emergence is linked to diminished 
quality of life and highly critical outcomes. These include: diminished adherence to highly active 
antiretroviral therapy (HAART) and further disease progression to Acquired Immunodeficiency 
Syndrome (AIDS).  AIDS is characterized by the CDC as a CD4 count below 200 cells/mm3 or 
development of specific opportunistic infections, including candidiasis of the pulmonary system, 
coccidiodomycosis, and Cryptococcus bacterial infections (CDC, 2012). Depressed PLWHA 
might have difficulty with the minutiae of a drug regimen (Gruber, Sorenson, & Haug, 2007). 
Factors identified as being associated with this include coordinating movement to take 
medications, difficulty timing correct dosage, and forgetting or skipping doses. Depression 
seems to cause individuals to recall adherence problems more frequently and report them more 
freely (Gruber et. al, 2007).  This tendency to fixate on mistakes, such as forgetting doses, is an 
important factor to account for in researching depression in HIV-infected gay and bisexual men. 
A challenging aspect of living with HIV is maintaining strict adherence to its associated 
medication regimen- typically in the form of highly active anti-retroviral therapy (HAART)- to 
suppress viral load, decrease risk of transmission, and prevent further progression to AIDS 
(Gruber, Sorensen, & Haug, 2007). Ninety-five percent of the prescribed dose must be taken in 
order to suppress viral load effectively. Due to the necessity for near perfect compliance, 
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mutation of HIV with consequential resistance is a concern (Fisher et. al, 2006).  HAART is 
considered a complex regimen as it involves taking three or more medications at several times 
over the course of the day.  Additionally, it is not free from adverse effects that affect desire, and 
ability, to take the medication.  According to Gruber and colleagues (2007), there are major 
barriers to HAART adherence.  These include: 1) variables in medication (e.g. adverse effects), 
2) patient variables (e.g. psychosocial problems), 3) patient-health care provider relationship 
variables, and 4) system of care variables. The second defined barrier (patient variables) is 
pertinent to the discussion about how depression qualifies as a significant psychosocial barrier to 
adhering to a HAART medication regimen (Gruber et. al, 2007).   
Depression has the ability to increase risk-taking behavior and reduce adherence to 
medications. Its development in PLWHA can contribute to severe alterations in immune 
functioning.  These alterations include reduced natural killer (NK) cell levels and impaired 
ability of lymphocytes to proliferate (Alciati, Gallo, Monforte, Brambilla, & Mellado, 2007).  
Deficiency of NK cells contribute considerably to immune decline by reducing total natural 
immunity. A finding that bolsters the need to identify depression early, particularly in PLWHA, 
is that antiretroviral therapies (including HAART) do not improve the reductions in NK cells 
related to depression.  In order to maintain an appropriate viral load and reduce rates of 
mortality, PLWHA need to maintain the highest levels of immune functioning, which may not be 
possible with diminished NK cell levels (Alciati et. al, 2007).   
The formation of depression is multifactorial regardless of population; however, in each 
at-risk population the factors that contribute to its formation are unique to that group of people 
and their experiences. In HIV-infected gay and bisexual men, depression and depressive 
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symptoms are related to factors such as sexuality (social and internalized homophobia), felt 
stigma, abuse of drugs and alcohol, living with HIV, the implications of the HIV epidemic, body 
image, social isolation, loss of family and friends- either through disease progression or through 
separation (Körner et. al, 2008) Detection of depression in this population is complicated by the 
overlap in symptoms of depression and HIV/AIDs. Somatic symptoms of depression are defined 
in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) as significant weight 
loss, sleep disorders, psychomotor agitation or suppression, fatigue, feelings of worthlessness, 
diminished ability to concentrate, and suicidality (American Psychiatric Association, 2013).  
The somatic symptoms of HIV generally mimic the symptoms listed above, often 
confounding the health care providers of these patients. There are four recognizable situations 
discussed by Körner and colleagues (2008) that complicate the process of defining depression in 
HIV-infected gay and bisexual men. First is the gap between recognition of depressive symptoms 
and the health care provider’s ability to match a patient’s symptoms to the psychiatric 
designations needed for a true diagnosis. Second is the reluctance of many to accept a diagnosis 
of depression, particularly when only experiencing somatic symptoms. Third is the hesitance 
experienced when a standardized instrument detects depressive symptoms or makes a diagnosis 
of depression but the individual perceives his or her experiences to be a result of poverty, loss of 
jobs, unstable housing, social isolation, or the diagnosis of HIV. The fourth situation that 
complicates this process is determining if depression occurred primary to an HIV diagnosis or 
secondary to an HIV diagnosis. In the instances of depression occurring primary to HIV, the 
patient may have experienced symptoms or received a diagnosis prior to being diagnosed with 
HIV. In the instances of depression occurring secondary to HIV, the patient may be experiencing 
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symptoms as a result of: the diagnosis itself, felt stigmatization, or side effects from antiretroviral 
therapies (Körner et. al, 2008) 
The CDC estimates prevalence of HIV in the United States alone at 1,218,400 people, 
with an incidence rate of 50,000 new infections each year (CDC, 2015). Suffering from mental 
health problems (i.e. depression, anxiety, and suicidality) and adverse social conditions may 
produce significantly enhanced vulnerability to infection with HIV. These are known as 
syndemics and may affect an individual or population such as in gay and bisexual men 
(Sivasubramanian et. al, 2011). Because depression is the most significant mental health concern 
affecting HIV-infected individuals, screening for depression is a highly-indicated aspect of the 
routine care of PLWHA.  Screening of depression in this population can potentiate means for 
treatment, improve health-protective behavior, enhance quality of life, and ameliorate rates of 
mortality (Sherr, Clucas, Harding, Sibley & Catalan, 2011). Having an understanding of these 
characteristics is important in tailoring interventions and treatments to improve adherence to 
medications, increase access to mental health counseling, and reduce stigmatization. 
Purpose 
 The purpose of this comprehensive review of the literature is to: 1) identify the 
instruments most commonly used in the detection of depression in HIV-infected, adult gay and 
bisexual men; 2) examine which of the identified tools have the highest efficacy in diagnosing 
depression in this population; and 3) report the commonly cited strengths and weaknesses of 
these instruments. Additionally, this review will provide a window into a sampling of available 
clinical instruments used to diagnose depression in this population while providing rationales for 
the importance of a strong screening instrument with suggestions for further research. 
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Methods 
An initial literature review search was performed using research databases accessed 
through EBSCOhost. These included CINAHL Plus with Full Text, MEDLINE, PsychINFO, and 
the Health and Psychosocial Instruments. Key terms used in the initial search included: (MH 
"Human Immunodeficiency Virus") OR HIV OR "HIV-infected patient" OR HIV/AIDs OR 
"Human Immunodeficiency Virus") AND (anxiety or depress*) AND (men or male) AND 
(stigma* or shame or ridicule or prejudice* or stereotype*) AND instrument*. This search 
yielded n = 195 articles. Upon review of these articles, abstracts, and research aims, the number 
of accepted results was further reduced to n = 88 articles. These 88 articles were hand reviewed 
for relevance; 56 were excluded for not fully meeting inclusion criteria, and 42 remained. A last 
more detailed review was performed, excluding more articles due to lack of fit in this thesis. 
Finally, 15 articles remained for inclusion into this work. 
The results were limited for inclusion by English language, evidence-based practice, 
being peer-reviewed, and using research instruments, questionnaires, or scales. Articles were 
excluded from the search if they did not relate to adult populations (operationalized as being 18 
years and older), HIV seropositive individuals, and depression or depressive symptomology. An 
important note to make is the presence of HIV seropositive women and Trans* women in several 
of the articles selected for inclusion. For the purposes of this literature review, however, the only 
data considered for inclusion and discussion is that pertaining to depression in HIV-infected gay 




Upon analysis of the literature, this study revealed some of the most commonly used 
clinical instruments in HIV-infected gay and bisexual men with analysis of their efficacy in this 
population. In Sherr and colleagues (2011) systematic review, 1,015 articles were generated with 
90 studies included for analysis. Of the 90 articles, 58 addressed only HIV-infected gay and 
bisexual men with emphasis on the challenges of detecting depression in this population (Sherr, 
2011). The final 32 articles included in the systematic review addressed both HIV-infected gay 
and bisexual men in addition to other HIV-infected adult populations. The articles included in 
the Sherr study (2011) incorporated depression with other outcomes: anxiety, coping, quality of 
life (QOL), fatigue, smoking, immunological measures, adherence to medication, adverse effects 
of medications, HIV progression, and risk-taking behaviors. As noted throughout, there is a 
significant overlap between somatization of depression and the experienced somatic symptoms 
of HIV requiring clinicians to incorporate instruments that assess the “other outcomes” of 
depression. 
Twenty-one standardized instruments were analyzed in the above systematic review to 
detect depression. As there is an abundance of clinical instrumentation used in the detection and 
diagnosis of depression, this study focused on the five most commonly used tools from this 
systematic review in addition with several tools from separate articles. The five most common 
tools from the systematic review include the Beck Depression Inventory (BDI), the Hamilton 
Depression Rating Scale (HAM-D), the Center for Epidemiological Studies Depression Scale 
(CES-D), the Profile of Mood States (POMS) depression subscale, and the Clinical Global 
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Impression (CGI). A feature typical to all of the studied literature is the comparison to the Mini 
International Neuropsychiatric Interview (MINI) for efficacy. 
The MINI is a brief, structured interview developed to detect the 16 major psychiatric 
disorders within Axis I of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 
Importantly, studies that incorporate the MINI indicate high validity and reliability in detecting 
major depressive episodes, dysthymia, and suicidality (Sherr et. al, 2011). The MINI is 
considered the gold standard in detecting depressive symptoms in all populations; however, it 
does not consider chronic illness- such as HIV/AIDS. This leads to difficulty in differentiating 
between the somatic symptoms of depression and HIV and lends itself to the need to determine a 
screening tool that is most effective for HIV-infected gay and bisexual men. 
Sherr and colleagues (2011) determined that the prevalence of depression in HIV-
infected adults is around 51.6%. However, the true prevalence of depression in HIV-infected gay 
and bisexual men is difficult to determine due to the use of different screening instruments and 
the potential for persons to keep their sexual orientation hidden from their healthcare provider 
(Körner et. al, 2008). For the purposes of this study, the prevalence rates of depression 
determined by each screening instrument were compared to the average prevalence of depression 
in HIV-infected adults (51.6%). The results were then generalized with the intention of 
establishing a correlation between the instrument used and its efficacy in detecting depression. 
Additionally, several of the studies reviewed made concerted efforts to control for the somatic 
items that often skew the results of screenings. This occurs through the inclusion of additional 
analyses with subscales that do not include somatic items. For example, the BDI includes 
subscales specifically addressing depression (BDI Affective and BDI Cognitive/Affective). This 
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is typically used in addition to the standard BDI to better grasp the affective aspects of 
depression, rather than the somatic (Sherr et. al, 2011). 
The BDI was cited 30 times in the systematic review (its subscales were cited 13 times). 
It was used with various cut-off scores meaning each researcher established a statistical 
prevalence after a certain number of questions were answered per the inventory. For instance, a 
study with sample size of n = 299 HIV-infected gay and bisexual men determined a diagnosis of 
moderate or severe levels of depressive symptoms could be accurately identified in 71% of the 
sample after 16 or more questions were answered. Over the 30 instances of its use, the average 
prevalence of depression determined by the BDI was 46.7% (Sherr et. al, 2011). 
The HAM-D was cited 20 times in the systematic review and its subscales were cited 11 
times. As with BDI, the HAM-D was used with varying cut-off scores, however, it determined 
the average prevalence of depression was 49%. The CES-D was cited 19 times throughout the 
review and it determined the average prevalence of depression as 49.4%. The POMS 
Depression-Dejection subscale is cited 15 times throughout the systematic review and 
determined the average prevalence of depression to be 36.2%. The CGI is cited 14 times 
throughout the review and determined the average prevalence of depression to be 56.4% (Sherr 
et. al, 2011). 
An additional instrument from articles beyond the Sherr and colleagues (2011) systematic 
review included use of the Brief Symptom Inventory-18 (BSI-18). The BSI-18 is an 18-question 
screening tool for psychiatric distress, anxiety, depression, and somatization. The BSI-18 was 
validated against the MINI and accurately described depression and depressive symptoms in N = 
150 HIV-infected gay and bisexual men, 62% (n = 93) (Sivasubramanian et. al, 2011). In 
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addition to assessing the efficacy of the BSI-18 through validation with the MINI, the instrument 
incorporated contributing factors to distress, particularly those relevant to minority populations 
with HIV such as: homelessness, substance abuse, and disrupted social support 
(Sivasubramanian et. al, 2011).  
In an attempt to determine whether the length of time needed to complete a screening 
made a significant difference in results, researchers compared three clinical instruments with 
their shortened form or their subscale. Literature indicates that long depression screening tools 
and those requiring an interview between the health care provider and patient were often left un-
administered or incomplete (Akena, Joska, Obuku, & Stein, 2013). This particularly in HIV-
infected individuals; required multiple follow-up appointments and screenings.  
A study performed by Akena and colleagues (2013) tested the validity of two brief scales 
(and their shortened counterparts) to a long depression-screening instrument for PLWHA. These 
included 1) the Patient Health Questionnaire-9 (PHQ-9) and its shortened version the PHQ-2; 2) 
the Kessler-10 (K-10) and its shortened version the K-6; and 3) the CES-D (also mentioned by 
Sherr et. al, 2011). The MINI was used as the standard to compare validity and efficacy in 
detecting depression. The PHQ-9 measures depressive symptoms and their reported severity on a 
Likert-type scale and focuses on the nine criteria for diagnosis of depressive disorders per the 
DSM IV (Akena et. al, 2013).  
When compared to the MINI, the PHQ-9 was able to correctly identify depression 
89.36% of the time in this population with a sensitivity of 91.67% and specificity of 89.02% 
(Akena et. al, 2013). The K-10 was able to correctly identify depression 74.7% of the time with 
sensitivity of 83.33% and specificity of 72.37% (Akena et. al, 2013). Finally, the CES-D was 
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able to correctly identify depression 82.95% of the time with a sensitivity of 88.95% and a 
specificity of 81.43 % (Akena et. al, 2013). The overall results of the study indicate that the 
shortened questionnaires (PHQ-2 and K-6) experienced decreased sensitivity and specificity as 
well as a severely diminished ability to correctly identify depression. Additionally, it showed that 
the PHQ-9 was the most effective in determining depressive symptoms in HIV-infected gay and 
bisexual men.  
Limitations 
 Determining the efficacy of the clinical instruments in this study was limited by several 
factors. A potential threat to the generalizability of the study is that many of studies reviewed 
had smaller sample sizes. This may have been brought about by fear of revealing sexuality to 
providers, lack of access due to socio-demographics and socio-economics, and unwillingness to 
fully complete screenings (by both health care providers and patients). Additionally, a great deal 
of the literature included for analysis incorporated HIV-infected gay and bisexual men from 
high-income countries such as the United States or United Kingdom. This creates a gap in the 
understanding of this population from low-income and developing countries. 
Further factors limiting discernment of efficacy were the 1) inability to discern baseline 
depression from depression secondary to HIV and 2) the inability to distinguish between 
somatization of depression versus HIV symptomology/disease progression. This was researched 
in several of the studies; however, there was no singular instrument used to address these limits. 
Instead, use of a primary screening tool with follow up subscales and interviews was necessary. 
A dilemma with this process was the inability or unwillingness of health care providers and 
patients to complete several screenings and interviews. This may have been a product of time 
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constraints on medical visits in primary care settings or a function of somatic disease sequelae in 
the patient. Thus, many of the studies included in this analysis themselves noted significant 
participation limitations. 
Future Research and Impact on Clinical Practice  
Health care providers should continue to use validated instruments to detect/diagnose 
depression in HIV-infected gay and bisexual men. The research has suggested the risk in this 
population for developing depression is double that of other non-HIV-infected populations (both 
heterosexual and homosexual). Further, due to the negative sequelae of depression on the 
management of HIV infection, early detection and intervention are crucial. This study was 
unable to determine a single best instrument to use for HIV-infected gay and bisexual men. 
However, it was able to determine that inclusion of minority-specific variables (unstable 
housing, lack of access to care, substance use) and control for somatic symptoms was effective in 
the early detection of depression in HIV-infected gay and bisexual men. The clinical scales that 
stood out the most include CGI, BSI-18, and the BDI. 
Future research of this topic should delve further into understanding the efficacy of the 
CGI, BSI-18, and BDI on this population. The research should include a broader scope of studies 
with an aim focused on determining the best depression-seeking clinical tools for these persons. 
Assessing variations within this population (i.e. HIV-infected gay and bisexual men who are 
unstably housed versus HIV-infected gay and bisexual men who are IV drug users) would also 
be of value. After obtaining a comprehensive screening instrument, researchers should explore 
the best interventions to encourage positive health outcomes in HIV-infected gay and bisexual 
men.   
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Nurses are integral agents in the process of accessing health care, providing skills that are 
vital to the detection of disruptions in both mental and physical health. Nurses perform 
admission assessments, act as conduits to future inpatient and outpatient placements, provide 
referrals to further specialized care, and can advocate for patient needs. Nurse researchers are 
able to develop an evidence-base of best practices applicable to clinical settings. In regard to 
detecting depression in HIV-infected gay and bisexual men, nurses are front line care providers. 
They provide initial assessments and are able to devote the significant time to their patients. In 
instances of encounters with HIV-infected gay and bisexual patients, nurses should include 
depression screenings as routine care measures. 
Future nursing research should focus on the development of an evidence-based tool to 
influence best practices of care in HIV-infected gay and bisexual men, including those tools to 
screen for depression in this high-risk population. Nurses in the clinical setting can use the best 
appropriate comprehensive depression-screening instrument to determine if depression is an 
active pathology in their HIV-infected gay and bisexual patients. This can help facilitate 
improvement of the adherence to HAART, reduce transmission of HIV, increase the quality and 
length of life, reduce risk-taking behaviors, protect against suicide, and reduce the sequelae of 
both HIV and depression. 
Nursing Education 
Registered nurses and nurse practitioners often have limited exposure to issues relevant to 
GLBT populations (Blackwell, 2015). As such, the experiences felt by nurses are not the same as 
those of HIV-infected gay and bisexual men. Further, nurses are not exempt from displaying 
behaviors described by attribution theory in that they may also ascribe blame to gay and bisexual 
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men for their infection with HIV (Ramirez et. al, 2013). Ramirez and colleagues (2013) also 
posit that the traditional health promotion strategy for HIV prevention of being personally 
responsible for one’s health, such as using a condom or getting tested regularly, may be a 
contributing factor to the societal development of homophobia. The lack of knowledge, 
ascription of blame, and traditional health promotion model can be addressed through nursing 
education.  
Körner et. al (2008), provided surveys of general practitioners indicating depression in 
HIV-infected gay and bisexual men was detected with more frequency when sexuality was 
considered during initial assessments (Körner et. al, 2008). As homophobia and 
heteronormativity are present in medical settings, research suggests providers should begin to 
incorporate means to determine sexuality and provide interventions to counteract negative 
outcomes (Körner et. al, 2008). Homophobia is a term that encompasses fear of and aversion to 
homosexuality or homosexuals as well as discrimination and prejudice that accompanies 
(Blackwell, 2015). Heteronormativity is described as “the attitude that heterosexuality is the only 
normal and natural expression of sexuality” (Merriam-Webster, 2017) These ideas can be 
relayed insidiously within healthcare settings by presuming all individuals are heterosexual and 
ascribe to heterosexual relationships and marriage rather than asking openly about sexual 
relationships with all genders (Blackwell, 2015). 
Blackwell (2015) describes the need for education related to mental health in gay and 
bisexual men as there is homophobia and persistent misunderstanding regarding the needs of this 
population. Through incorporation of nursing curricula with an emphasis on gay and bisexual 
men, nurses can develop better perspectives towards the experiences of gay and bisexual men 
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and deeper understandings of their mental health needs (Blackwell, 2015). During health 
promotion activities, nurses can tackle the current HIV-prevention model of personal 
responsibility and push for a more empathetic message of collective responsibility, thus pulling 
away from placing personal blame (Ramirez et, al, 2013). Lastly, nurses can provide a safe space 
for HIV-infected gay and bisexual men to access health care through asking openly about sexual 







































Table 1: Table of Evidence 
Inclusion Criteria: English-language, peer reviewed, evidence-based, abstract available, adult population, full-text available, 
relevant to literature analysis 
 
Exclusion Criteria: Pediatric population (<18 years old), not English-language, not relevant to literature analysis 
 
Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Akena, D., Joska, J., 
Obuku, E. A., & Stein, D. J. 
(2013). Sensitivity and 
specificity of clinician 
administered screening 
instruments in detecting 
depression among HIV 
positive individuals in 




• Mini International 
Neuropsychiatric 
Instrument (MINI) used 
as gold standard  
• Patient Health 
Questionnaire-9 (PHQ-
9)- AUC 0.964; CI of 0.92-
0.99; optimal score of 10; 
sensitivity 0.91; specificity 
0.81 
BEST performing 
instrument of this study 
• PHQ-2 = shortened 
version of PHQ-9; AUC 
of 0.82; CI of 0.71-0.93; 
optimal score of 3; 
sensitivity 0.83; specificity 
0.70 
• Centre for 
Epidemiological Surveys 
for Depression (CES-D)- 
AUC of 0.944; CI 0.89-
0.99; optimal score of 18; 
sensitivity 0.88; specificity 
0.81 
• Kessler-10 (K-10)- AUC 
of 0.824; CI 0.72-0.93; 
• Coefficient 0.75 or 
greater is adequate  
• BRIEF instruments may 
be preferable in busy 
areas  
• HIV positive patients 
presented with MINI 
defined depression in 
HIV-primary care 
clinics TWICE as often 
as in non-HIV primary 
health care settings  
• MINI confirmed 
(w/sociodemographic 
info) the high burden of 
depression among 
PLWHA in low/middle 
income countries 
• All 3 instruments were 
highly accurate in 
ability to ID depression 
r/t MINI 
• PHQ-9 validated 
against the MINI had 
very good psychometric 
properties; however, the 
shortened versions of 
• HIV-positive 
individuals 
• Population Size 
= 368 
-71% (261) were 
women, mean 
age = 31 (SD10); 
n=241 employed; 





• Sample Size = 
276 
• Uganda • Nurses (RN) were 
able to successfully 
administer the 3 
questionnaires (PHQ-
9, K-10, and CES-D) 
in a low/middle-
income setting where 
patients have low 
literacy. 
• Having the ability to 
screen at the level of 
the RN provides 
earlier detection of 
depression and 
greater access to 
resources. 
• One of the roles of 
nursing = patient 
education. If 
screening results in 
positive markers of 






optimal score of 23; 
sensitivity 0.83; specificity 
0.72 
• K-6- shortened K-10; 
AUC of 0.81; CI 0.71-
0.93; optimal score of 13; 
sensitivity 0.77; specificity 
0.67 
both questionnaires 
were found to decrease 
both sensitivity and 
specificity of the results 
• K-10 did not perform as 
well as the CES-D and 
PHQ-9 probably b/c it 
screens for 
“psychological distress” 
or “common mental 
disorders” rather than 









































Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Alciati, A., Gallo, L., 
Monforte, A. 




immunological changes and  
combination antiretroviral 




Clinical &  
Experimental, 22(1), 33-40.  
doi:10.1002/hup.813 
After MINI diagnosis  
interviewed w/:  
1) Structured Clinical 
Interview for DSM-III-
R/DSM-IV Axis I  
disorders to confirm the 
diagnosis 
2) 17-Item Hamilton 
Depression Rating Scale 
(HDRS)- must score >20 
to be selected 
3) If negative HDRS screen, 
participants self-
administered the Beck 
Depression Inventory 
(BDI)- if <4 and 0 on the 
question “I do not feel sad” 
• Natural killer cells are 
an appropriate marker 
of the effect of 
psychological disorders 
(e.g. depression) on 
immune functioning 
• Depressive symptoms 
& stress (individual or 
together) r/t decreased 
NK and CD8 T-cells 
• MDD  functional 
alterations of NK cells 
(found in HIV+ 
women) 
• Improvement of 
depression/symptoms 
r/t increased NK cell 
activity 
• After analyzing 
different groups of 
HIV-infected people 
based on the form of 
therapy they were 
engaging in, the study 
found: there is no form 
of antiretroviral therapy 
that will improve 











age, r/f (i.e 
IVDU or sexual 
transmission), 







• n1=36 PLWHA 
with MDD – 
20M, 16F 
• n2=77 PLWHA 




learned of status 





drug use, >60 
alcoholic 
• Italy • Aim of study was to 
investigate MDD on 
the immunological 
function of PLWHA 
 
• This study shows 
ARV therapy does 
NOT improve 
changes in NK cell 
levels r/t MDD 
• Limitation: 
Low # of patients 
Did not account for felt 
stress (stress can account 
for reduced immune 
functioning) 
• The nurse should 
encourage continued 

















regimen with 2 




























Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Blank, M., Himelhoch, S., 
Balaji, A., 
Metzger, D., Dixon, L., 
Rose, C.,  
Oraka, E., Davis-Vogel, A.,  
Thompson, W., 
Heffelfinger, J.  
(2014). A Multisite Study 
of the  
Prevalence of HIV with 
Rapid  
Testing in Mental Health 
Settings.  




• Short Form 12- Item 
Health Survey (SF-12); 
from the Medical 
Outcomes Study 
-Assess comprehensive 
health status and 
functioning 
• Risk Assessment Battery 
(RAB) 
-Assess sexual orientation, 
homelessness/unstable 
housing, involvement with 
justice system, 
type/frequency of drug 
use, IDU (With source of 
needles) 




1) Depression/ functioning 
2) Relationships 
3) Self-harm 
4) Emotional lability 
5) Psychosis 
6) Substance Abuse 
-NOT diagnostic-specific 
(e.g. depression only) 
-Includes measures of a 
broad range of symptoms 
r/t mental illness 
• Algorithm to create 3 
mutually exclusive 
categories based on DSM-
IV diagnoses of psychiatric 
• Rate of infection was 
higher in Baltimore 
(5.9%) than 
Philadelphia (3.9%) 
• 288 = from university-
based inpatient psych 
units; 17 were HIV-
infected (5.9%) 
• 273 = from ICM 
programs; 14 were 
HIV-infected (5.1%) 
• 501 = CMHCs, 20 were 
HIV-infected 
• Philadelphia: 
24/608 tested positive; 
21/24 previously knew 
of status 
• Baltimore: 27/454 
tested positive; 17/27 
previously knew of 
status 
• Age: 
-40-49 had highest HIV 
prevalence (6.7%) 
• Race: 
-Black participants (692 
people) had highest 
HIV prevalence (6.2) 
over other races 
(White- 196 people; 
other- 166 people) 
• Homeless/unstably 
housed: 14/173 (8.1%) 
people had HIV  
• N=1061 
621M, 436F 
• 65.7% = Black 
• 51 people= 
confirmed HIV+ 
• 570 = ONLY 
psychiatric 
disorder 




-227 (59.4%) had 
affective disorder 
-11 (1.9%) had 
other psych 
diagnosis 




• 141 = substance 
abuse disorder 







• Evaluation of patients 
in this study occurred 
over routine inpatient, 
routine outpatient, 
and intensive case 
management mental 
health settings 
• HIV = highly 
prevalent in people 
ALREADY receiving 
mental health care 
• Patterns in HIV 
infection are similar 
to this population as 
well: Black race, 
homosexual/bisexual, 
HCV infection, and 
IVDU 
• Psychiatric severity 
was DIRECTLY 
associated with HIV 
infection  
• HOWEVER – 
prevalence of HIV 
did not differ between 
the 3 settings 
• Nurses should 
implement continued 
screening (using the 
tested instruments) 
and intervention in 
HIV+ individuals 
• Nurses should 
perform HIV-
screening as part of 
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and substance abuse 
disorders (commonly co-
occur) 
1) Psychiatric diagnosis only 




3) Those with substance 
dependence/abuse 
diagnosis only 
• Colorado Symptom 
Index for psychiatric 
symptom severity 
-47% increased r/f HIV 
among people w/ scores 
>30 (SEVERE psych 
symptoms) – used in study 
to show that more severe 
psych symptoms = > 
chance of being HIV-
infected  
• Coinfection with HCV: 
17/51 HIV-positive 
people 
• 10 of the 96-reported 
homosexual or bisexual 
individuals were HIV 
positive 
• No statistical 
significance for BASIS-
24 
• Emotional lability and 
total RAB score were 
significantly different 
between HIV-infected 
and non-HIV infected 
populations  
• NO difference in 
prevalence of HIV by 
service setting 
• Need for long-term 
caring relationships b/c 
access to care in the 
community for 
PLWHA and mental 
illness is diminished by: 
substance abuse, 











health assessment  
• See article for some 
“System-level 
barriers” that must be 





Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Körner, H., Newman, C., 
Mao, L., Kippax, S., Kidd, 
M., & Saltman, D. (2008). 
'It's really a myriad of 
different signals, not just 
the textbook': The 
complexities of diagnosing 
depression in gay men in 
general practice. Mental 
Health in Family 
Medicine, 5, 167-175. 




• Explored diagnosis, tx, 
management of depression 
r/t HIV status, gender, and 
sexuality 
• No instruments used to 
diagnose depression in this 
instance 
• Depression associated 
with lower quality of 
life, unemployment, 
higher sexual risk 
taking, non-adherence 
to ARV treatment, 
disease progression 
• Long-term, trusting 
relationships with HCPs 
resulted in better care 
• Major theme regarding 
depression in HIV-
infected gay men = 
loss: income, careers, 
relationships, family, 
support, future… 
• Triggers to developing 
depression, determined 
by HCPs, = pos 
diagnosis, starting ARV 
therapy, AIDS defining 
illness 
- Long-term HIV 
diagnosis and loss 
of friend/loved-one 
to disease = 
MAJOR cause of 
depression 
- BE ALERT 
• N = 16 HCPs 
were interviewed  
-14M, 2F 
-Have worked in 
HIV medicine 










• General practitioners 
in this study 
considered all facets 




effects of HIV 
epidemic (esp. as it 
affects gay men 




is a major predictor 
of suicidality 
• Unique challenges to 
HCP; if depression is 
1o to HIV = may/may 
not have had hx of 
depression; if 
depression is 2o to 
HIV- may be the 
result of infection or 
SE of ARV/txs 





sometimes hard to 
detect b/c mimic 
disease progression 




• L: Diagnosis of 
depression is affected 
by demographic of 
patients w/i primary 
care setting 
• If pt. able to visit 
more often, more 
likely to have 
symptoms recognized 
• Some HCPs may 
meet resistance from 
pt. in being labelled 
“depressed” 




instruments but not to 
pt themselves 
• This study reinforces 
the need to 
DIRECTLY question 
patients regarding 
their mental health – 
direct questioning 
alleviates patient 




• HCPs understood 
depression’s 






Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Leserman, J. (2008). Role 
of depression, stress, and 
trauma in HIV disease 
progression. Psychosomatic 
Medicine, 70(5), 539-545. 
doi:10.1097/PSY.0b013e31
81777a5f 
• CES-D (see Table 1 in 
article) 
-Findings at baseline: 
decreased CD4 count, 
increased mortality, 
increased r/f AIDS 
• HDRS 
- Findings at baseline: 
increased r/f AIDS 
• SF Men’s Health 
(N=400) 
- Depressed at study 
entry progressed to 
AIDS 1.4 years sooner 
than non-depressed 
counterparts 
- At 5.5 years, baseline 
depression was r/t 
CD4+ decline (did not 
lead to AIDS/mortality) 
- At 7 years – elevated 
depressive symptoms = 
67% increased r/f 
mortality 
• M AIDS CS- Baseline 
depression- before HIV 
diagnosis- was not 
associated with HIV 
progression 8 years 
after infection 
- Increase in depression 
6-18 months BEFORE 
an AIDS diagnosis 
- Re-analysis at 13 
years indicated somatic 
symptoms at baseline 
associated with shorter 
survival time BUT 
NOT shorter time to 
AIDS- opportunistic 
disease 
(fatigue, poor appetite, 
trouble concentrating) 
 




study) – prior to 
initiation of 
HAART 
• N = 400 
asymptomatic, 




• N = 1339 gay 
men 
• Longitudinal 
study (8 years) 
• CHIP 
• N = 96 
asymptomatic 
HIV+ gay men 













worded items lead to 
better predictions of 
survival (i.e. hopeful 
vs. sad) 
• Is depression a 
predictor/result of 
disease progression? 
• We must measure 
depression as 
baseline or measure 
in the time interval 
before HIV-related 
changes to immune 
status 
• Depression scores are 
typically elevated in 
the year before 
AIDS-related death 
• Be aware of factors 
that contribute to 
depressive changes in 
this population: 
• “Trauma” in the 
sense of abuse, 
assault, unexpected 





individuals who have 
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• Coping in Health and 
Illness Project (CHIP) = 
depressive symptoms 
q6 months up to 9 years 
• In CHIP (N = 96) 
- Each increase of 1 
severe depressive 
symptom = 2x r/f 
AIDS at 5.5 years; 
r/f clinical AIDS 
condition (but not 
AIDS) was 3x in 9 
years 
• 74% of participants 
above median 
progressed to AIDS 
• 40% of participants 
below median did not 
• Depression with 
HAART use =  
- > 5x r/f progression 
to AIDS 
- Slower suppression 
of the virus 
- Shorter survival 
time 
• Cumulative depression 
(w/ and w/o somatic 
symptoms) = 
progresson  AIDS, 
nonadherence to meds, 




• AIDS symptoms and 
CD4 count do not 
predict major 
lived with HIV for a 
long time (partners 
have passed, close 
friends, they may be 
very ill) 
• Finding meaning in 
loss of loved ones, 
less distress when 
notified about change 
in serostatus = slower 
progression of HIV 
• Discontinuation of 
HAART and non-
adherence may lead 





mental health services 
are <likely to die 
from AIDS-related 
causes 





• Involve case 
management; able to 
provide psychiatric 
resources, and refer 
therapies 
• Limited by: 
• Our poor 
understanding of the 
biological mediators 
for HIV infection 
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depression 
• Depressive symptoms 
DO predict 
development of AIDS 
and other AIDS related 
conditions 
• Bereavement section (N 
= 85 gay men) 
- Had a 
partners/close 
friends die of AIDS 
- CD4 count rapidly 
dropped during 3-4 
years following 
- Unexplained by 
non-adherence or 
health habits 
- Did not show 
progression to 
AIDS or mortality 
though 
- Immune markers 
associated with 
increase r/f AIDS 
(neopterin- immune 
activation marker, 










• Need for more 
research into best 
psychiatric therapies  
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Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Passos, S. M., Souza, L. D., 
& Spessato, B. C. (2014). 
High prevalence of suicide 
risk in people living with 
HIV: who is at higher risk? 




• MINI – Module C 
- Assess suicide risk 
- Module C = 5 
questions regarding 




• Clinical interview: 
- Time since diagnosis, 
period on and current 
use of ARV meds and 
pt. perception of social 
support r/t infection 
• Brazilian versions of: 




- Hospital Anxiety and 
Depression Scale 
(HAD) 
• Reinforces research 
describing high 
prevalence of suicide in 
this population 
compared to individuals 
with other chronic 
diseases 
• R/F: suicide increased 
with length of diagnosis  
• n = 25 diagnosis < 12 
months; n=10 
determined at risk for 
suicide (29.4%) 
• n = 141 diagnosis > 13 
months; n = 41 at risk 
for suicide/arfs (29.1%) 
• Stage of infection: 
->Asymptomatic –
n=20; n=13 arfs 
(44.8%) 
->Symptomatic - 
n=5; n=2 arfs 
(40.0%) 
->AIDS – n=177; 
n=57 arfs (32.2%) 
• CD4 < 499; n=68, n=28 
arfs (41.2%) 
• CD4 >500; n = 65, 
n=19 arfs (29.2%) 
• Of the total sample: 49 
patients (23.2%) 
reported attempting 
suicide at least once; 
34.1% arfs 
• N = 262 
individuals with 
HIV (>18 years 
old) 
• 101M, 110F 
• M, n = 24 at r/f 
suicide 




• This study delves into 
HIV+ individuals as a 





lack of support, 
underlying mental 
health disorders 
(prior to diagnosis) 
• This population is at 
very high risk for 
suicide 
• Considering /rf: 
HCPs should take 
every effort to 
implement 
protective/preventativ
e measures  
• Routinely evaluate 
HIV+ patients for 
suicidality, 
depression 





Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Ramirez-Valles, J., Molina, 
Y., & Dirkes, J. (2013). 
Stigma towards PLWHA: 
The role of internalized 
homosexual stigma in 
Latino Gay/Bisexual Male 
and Transgender 
communities. AIDS 




• Internalized Homosexual 
Stigma 
• 17 item variable, validated 
in this population “Being 
gay means you will be 
alone when old” (Likert 
Scale) 
- a= 0.88 
• HIV/AIDS Personal 
Responsibility Beliefs 
- 3 items; Likert Scale; 
items capture existing 
definitions of personal 
responsibility in the 
realm of HIV/AIDS – 
the condition is the 
result of people’s own 
acts and values 
- a = .66 
• Discriminatory Actions 
Towards PLWHA 
- Developed similarly to 
PRB 
- 3 items; Likert scale 
- a = .70 
• Outcomes regarding 
stigmatization of Latino 
GBT individuals 
• Trans women included 
b/c experiences of 
stigmatization are 
comparable to those of 
G/B men 
• Discriminatory Actions 
Towards PLWHA 
• > discriminatory actions 
reported in Chicago  
• > discriminatory actions 
reported by U.S. 
residents than from 
foreign born  
• Bisexual men > 
discriminatory actions 
than gay men 
• No difference by 
serostatus 
• Discriminatory actions 
towards PLWHA was 





• It was found that there 
is an empirical and 
theoretical link between 
homosexual stigma and 
stigma towards 
PLWHA in sexual 
• 643 gay, bisexual 
men and trans 
women (MF) 
• Chicago N = 320 
• San Francisco N 
= 323 
• All Latino 
individuals 




• 18-73 years old 








• Nurses/HCPs must 
work to change the 
message of 
personality 
responsibility to more 
collective 
responsibility and 
empathy to others 
• Try to reduce the felt 
exposure of stigma 
against gay/bi men 
and PLWHA  
• Important public 
health problem as it 
hinders prevention 
efforts and negatively 
affects health of 
stigmatized people 
• Limited: cross 
sectional vs 
longitudinal or RCT 
• Study does not make 
generalizations about 
a population; but to 
test a model about 
attitudes towards 
PLWHA (and how 
they are shaped) 
• As internalized 
stigma indicates 
psychological distress 
and lack of social 
support HCPs should 
consider addressing 
those topics (perhaps 
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minorities 
• Latino GBT people 
who have internalized 
stigmatization project 
onto PLWHA (see 
HIV/AIDS as a 
punishment)  
• Appears that the 
message of personal 
responsibility in the 
prevention of 
HIV/AIDS (use a 
condom, get tested…) 
contributes to a culture 
of negative attitudes 























refer to social 
work/psych) 
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Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Sherr, L., Clucas, C., 
Harding, R., 
Sibley, E., & 
Catalan, J. (2011, 









• Beck Depression 
Inventory (BDI)- a score 
of 16 = “moderate” or 
“severe” levels of 
depressive symptoms; 
cited 30/90 times 
• Centers for 
Epidemiologic Studies- 
Depression Scale  
(CES-D)- a score of 16 = 
high level of depressive 
symptoms; cited 19/90 
times 
• Hamilton Depression 
Rating Scale (HAM-D)- a 
score of  
• Profile of Mood States- 
depression subscale 
(POMS)- a score of  
• Clinical Global 
Impression (CGI) 
• See Table III- Outcome 
measures of depression 
• 99 interventions were 
investigated and 







investigating effects of 
treatment- on HIV and 
its related conditions- 




- Enhancing efficacy 
is a valuable area of 
future research 
• The association btwn 
elevated symptoms of 
depression and disease 
progression = a 1.7x 
greater r/f mortality 
than those without any 
signs of elevated 
depression 
• Depression may be a 
cause of OR a marker 
of disease progression 
(as it has a complex 
interaction in both) 
• Depression ca influence 
immune function 
 
• All HIV+ 
individuals; 90 
articles included 
out of 1015 
• 65 studies 
recruited only 
men/mostly men 
• 31 recruited 
gay/bi men 
• 21 standardized 
instruments were 
used 
• 63 = 
United 
States 
• 4 = 
Canada 
• 2 = UK 
• 3 = Spain 
• 2 = Italy 
• 1 = 
Belgium 
• 2 = 
Germany 
• 2 = Hong-
Kong 
• 1 = Japan 
• 2 = 
Netherland
s 
• 1 = South 
Africa 
• 1 = 
Nigeria 
• 1 = Kenya 
• 1 = 
Tanzania 
• 2 = Brazil 
• HCPs should 




throughout the course 
of infection with HIV 
• When utilizing any of 
the depression 
inventories it is vital 
to control for somatic 
symptoms by either: 
excluding symptoms 
or conducting 
additional study into 
the mental health of 
the patient 
• Clearly demonstrates 
the need to 
incorporate regular 
measurement/treatme
nt of depression in 
this population 
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• Depression can be the 
consequence of disease 
progression or negative 
life/disease events  
trigger lower mood 
reactions 
• HIV+ people = 1.99x 
more likely to have 
MDD than HIV- people 
• Depression can emerge 
due to triggers during 
the progression of HIV 
(emotional reactions, 
chronic stress from 
social stigma, long-term 
physical discomfort) 
• Depression predicts 
quality of life better 
then severity in the 
stages of HIV/AIDS 



















Reference Instrumentation Outcomes Population Geographic  
Location 
Implications for HCPs & 
Limitations 
Sivasubramanian, M., 
Mimiaga, M. J., Mayer, K. 
H., Anand, V. R., Johnson, 
C. V., Prabhugate,
 P., & Safren, S. A. 
(2011). Suicidality, clinical 
depression, and anxiety 
disorders are highly 
prevalent in men who have 
sex with men in Mumbai, 
India: Findings from a 
community-recruited 
sample. Psychology, Health 
& Medicine, 16(4), 450-462 
• Mini International 
Neuropsychiatric Interview 
(MINI) 
- Cited in article 
- Validated, brief 
- English-language 
translated into Hindi 
for this study 
- Assesses psych 
disorders including 
MDD 
- Assessed outcomes: 
1) Current suicidality 
2) Current MDD 
3) Screen for any 
anxiety related 
disorder 
• Brief Symptom Inventory-
18 (BSI-18) 
- Validated in 
community 
populations 




• Rosenberg Self-Esteem 
Study 
- Validated tool to 
determine self-esteem 
of participants 
- Total score = 36 
- Likert scale questions 
of 1-4 
 
• India = highest # of 
HIV infections in Asia 
and 3rd largest epidemic 
in the world 
• MSM = highest risk 
group with increasing 
risk/prevalence 
• It is known that MSM 
experience worsened 
mental health in greater 
numbers in western 
nations such as US 
• Minority stress = model 
that explains health 
disparities in MSM and 
other sexual minorities 





- Evaluates internal 





- ^ presents as 
depression, anxiety, 
SI 
• Syndemics occur where 
mental health problems 
+ HIV = increased r/f 
transmission/progressio
n of disease 
• N = 150 M 
(MSM= men 
who have sex 
with men; gay/bi 
men – does not 
include Trans 
men) 
- Mean age = 
25.1 yo 
- 21% married 
to women 
- 24% = 
current 
MDD 
- 45% current 
suicidal 
ideation 
- 15% = high 
r/f suicide 
- 19% = 
moderate r/f 
suicide 
- 66% = low 
risk 
• References a 
second study in 
Chennai with 
210 MSM 









• This population is 
MORE likely to be 
HIV+ than the rest of 
the population 











• Because of pressure 
to remain hidden, 
finding sexual 
partners can be 
difficult and may 
increase high-risk 
behaviors (such as 
negotiating safe sex) 
– reinforce the need 
to continue safe 
sexual practices 
• Same-sex behavior is 
technically criminal 
in Indian states (other 
areas of the world); 
culturally; forbidden 
 increased r/f 
mental health 
disorders (reinforces 
need for screening 
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• Life Experiences Survey 
- Assess 40 stressful life 
events over past 6 
months 
- Includes: 
1) Pressure of 
marriage 
2) Pressure of have 
children 
3) Fear of having 
orientation 
discovered 
4) Discrimination  
5) Harassment 




about sex life 
3) Fear of having 
sexual orientation 
known 
4) Work pressure 
5) Other 
- However, 12 = 
average number of 
stressful life events 
reported 




study) through the 
Humsafar Trust (in 
Mumbai, India) 
- Included: 18-50 yo 
MSM  
- MSM defined as: 
• Self-esteem and 
perception of social 
support play roles in 
protecting from suicide, 
MDD, and other psych 
disorders 
unprotected 















-Gay or bi men 
-Other term 
- MF trans women 
were no included b/c 
they have different life 
experiences (called 




































Figure 1: Flow Diagram of Article Selection Process 
Key Search Terms - HIV, AIDS, immun*, “HIV and infection”, depress*, “depressive 
disorders”, instrument*, bisexual, homosexual, gay, man, men, male*, “HIV seropositivity”, and 
HAART 
Limiters - English language, evidence-based practice, peer-reviewed, and use of research 





















88 final articles were hand reviewed for 
relevance  
(N = 88) 
56 articles excluded after not fully meeting inclusion criteria, resulting in 
42 remaining articles 
(N = 42) 
A final, more detailed review was performed resulting in the exclusion of 
more articles for not fully pertaining to the aims of this study 
15 articles remained for inclusion in this analysis 
(N = 15) 
Databases used: CINAHL Plus with Full Text, MEDLINE, PsychINFO, and Heath and Psychosocial Instruments  
(MH "HIV-Infected Patients") OR (MH "Treatment Refusal") OR (MH "HIV Seropositivity") OR (MH “HIV 
Integrase Inhibitors") OR (MH "HIV treatment") AND HAART 
This search yielded 400 articles  
(N = 400) 
Databases used: CINAHL Plus with Full Text, MEDLINE, PsychINFO, and Heath and Psychosocial Instruments  
(MH "Human Immunodeficiency Virus") OR HIV OR "HIV-infected patient" OR HIV/AIDs OR "Human 
Immunodeficiency Virus") AND (anxiety or depress*) AND (men or male) AND (stigma* or shame or ridicule or 
prejudice* or stereotype*) AND instrument* 
This search yielded 195 articles 
(N = 195) 
Upon review of these articles, abstracts, and research aims, the number of accepted results was further reduced 
to 88 articles 
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